Front & Back Matter.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 1, doi. 10.1159/000521091
- Publication type:
- Article
Works matching IS 00302414 AND DT 2021 AND VI 99 AND IP 12
Results: 9
1
2
Contents Volume.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. I, doi. 10.1159/000520631
- Publication type:
- Article
3
Acknowledgement to Reviewers.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 813, doi. 10.1159/000520600
- Publication type:
- Article
4
Serum Matrix Metalloproteinase-8 and Myeloperoxidase Predict Survival after Resection of Colorectal Liver Metastases.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 766, doi. 10.1159/000518955
- By:
- Publication type:
- Article
5
Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 756, doi. 10.1159/000518612
- By:
- Publication type:
- Article
6
The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 790, doi. 10.1159/000518397
- By:
- Publication type:
- Article
7
Toward a Platform for Structured Data Acquisition in Oncology: A Pilot Study on Prostate Cancer Screening.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 802, doi. 10.1159/000518381
- By:
- Publication type:
- Article
8
Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 780, doi. 10.1159/000517490
- By:
- Publication type:
- Article
9
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16).
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 747, doi. 10.1159/000515951
- By:
- Publication type:
- Article